A novel proteinaceous protease inhibitor was isolated from the culture supernatant of Bacillus brevis HPD31. The protease inhibitor of B. brevis (designated BbrPI) was produced extracellularly in multiple forms having at least three different molecular weights. One of them, BbrPI-a, was purified to near homogeneity and only showed inhibitory activity toward serine proteases, such as trypsin, chymotrypsin, and subtilisin. BbrPI was presumed to form a trypsin-inhibitor complex in a molar ratio of 1:1. The inhibitor was found to be heat resistant at neutral and acidic pHs. The gene coding for BbrPI was cloned into Escherichia coli, and its nucleotide sequence was determined. The sequence suggested that BbrPI is produced with a signal peptide of 24 amino acid residues. The amino acid sequence of the protein deduced from the DNA sequence contained the amino acid sequences of amino termini of the inhibitors, a, b, and c, and their putative precursor determined chemically. The molecular weight of the precursor was about 33,000, and the molecular weights of inhibitors a, b, and c were about 22,000, 23,500, and 24,000, respectively. It is presumed that the secreted precursor protein, which is probably inactive, is cleaved by protease into several active protease inhibitor molecules. BbrPI shows no significant homology to the protease inhibitors described previously and is unique in not having any cysteine residues in its molecule.
Proteinaceous protease inhibitors (PIs) have been isolated from a large number of animals and plants and have been well characterized in regard to not only their protein nature but also their gene structures (5, 15) . While the primary physiological role of PIs is apparently the control of various protease activities, their cellular functions were found to be quite complex and diverse and still remain to be clarified. In contrast to the studies on inhibitors of eucaryotic cell origin, bacterial PIs have not been extensively characterized, except those secreted by Streptomyces species (11, 20) , a periplasmic PI of Escherichia coli (4) , and an intracellular PI of Bacillus subtilis (19, 21, 22) . A serine PI, called SSI, from Streptomyces albogriseolus has a molecular weight of about 11,500 and has been studied most extensively as to its structure-function relationship (20, 23) .
In this paper, we describe the isolation and characterization of an extracellular PI produced by B. brevis HPD31, named BbrPI, and the cloning and nucleotide sequence determination of the gene encoding the inhibitor. B. brevis HPD31 is a bacterium used as a potential host for efficient production of heterologous proteins (31) . It is of interest to determine whether or not the extracellular PI plays a role in the cell physiology of and efficient protein production by this organism.
MATERUILS AND METHODS
Bacterial strains, plasmids, and media. B. brevis HPD31 (26, 28) was grown in T2 medium (30) . E. coli XL1-Blue (Stratagene, San Diego, Calif.) was used as a cloning host and was grown in L-broth (18) . When required, ampicillin and neomycin were added at concentrations of 50 and 60 jj.g/ml, respectively. Plasmid pNH300 was constructed by inserting a multicloning site into pUB110 and will be described elsewhere. For cloning, pUC118 or pUC119 (32) was used as a vector. All cultivations were performed at 37°C with either reciprocal or rotary shaking.
Assay of PIs. The inhibitory activity of BbrPI was assayed under the conditions used for protease activity measurement. The protease and the inhibitor were mixed first, and after the mixture was held at 30°C for 5 min, the reaction was started by adding the substrate solution. One inhibitor unit was defined as the amount of inhibitor that caused a 50% reduction of protease activity under the assay conditions used.
Trypsin activity was routinely measured by incubating 1 ,ug (12 U) of bovine trypsin in 0.6 ml of 0.1 M Tris-HCl, pH 7.5, containing 10 mM CaCl2 and 0.4 mM N-benzoyl-Larginine-p-nitroanilide at 30°C. The increase in A405 was measured. When 0.5 mM N-p-tosyl-L-arginine methyl ester was used as the substrate, the change in A247 was followed. Trypsin activity was also estimated by using 0.5% (final concentration) Hammarsten casein as the substrate. After incubation at 30°C for 20 min, 0.6 ml of 1.7 M perchloric acid was added. After 30 min at room temperature, the suspension was centrifuged and the A275 of the supernatant was read. Proteases other than trypsin were assayed essentially by published methods (11 (24) . Plasmid DNA was prepared on a large or small scale by the method of Birnboim and Doly (3). Total RNA was extracted from B. brevis cells harboring pYAS03 (see below) grown to the late logarithmic phase of growth by the hotphenol method (1) and then was stored at -80°C in distilled water.
Transformation. The transformation of E. coli XL1-Blue and B. brevis HPD31 was performed by the methods of Hanahan (7) and Takagi et al. (27) , respectively.
Immunological procedures. Rabbit anti-PI-a antiserum was prepared by a standard procedure (8) . Immunoblot analysis of the products of B. brevis HPD31 was performed as described previously (29) . E. coli colonies producing PI were detected by using an in situ colony immunoassay, as described previously (9) .
Cloning of the PI gene. B. brevis DNA was partially digested with Sau3AI and then fractionated on a 0.6% agarose gel. DNA fragments of about 3 kb in length were isolated from the gel by electroelution. The 3-kb DNA fragments were inserted into the BamHI site of plasmid pUC118 and then used to transform E. coli XL1-Blue to ampicillin resistance. PI-producing transformants were detected on L plates by colony immunoassay. Of the 5,000 transformants examined, one clone was positive. The plasmid, pYAS01, of that clone contained a 7.2-kb insert. Deletion analysis of pYAS01 showed that a 2.2-kb BamHI fragment subcloned into pUC118 (pYAS02) contained the PI gene (see Fig. 4 ). Southern blot analysis of the B. brevis genome, in which the cloned DNA fragment was used as a hybridization probe, indicated the existence of a single PI gene in the genome (data not shown). The 1.5-kb BamHI-PstI fragment of pYAS02 (see Fig. 4 ), which contains the PI gene with its own promoter and terminator regions, was inserted between the BamHI and HindIII sites of a multicopy plasmid, pNH300, from B. brevis. The composite plasmid (pYAS03) thus constructed was used for overproduction of BbrPI.
DNA sequence analysis. DNA sequencing was carried out by the dideoxy chain termination method of Sanger et al. (25) . For the preparation of template single-stranded DNA, the M13 mp18, mpl9, pUC118, or pUC119 vector was used. Sequencing was performed for the entire lengths of both strands, and all of the ends of the DNA fragments used overlapped one another.
Primer extension assay. The deoxyoligonucleotide 5'-GACGGAAAGCTCYTTTACTG-3', which is complementary to the nucleotide sequence from 551 to 570 shown in Fig. 3 , was synthesized at the Center for Gene Research of Nagoya University and used as a primer. Total RNA extracted from B. brevis HPD31 harboring pYAS03 (100 ,ug) and the above-described primer DNA (200 ng) were used for the primer extension assay, as described previously (6) . The length of the primer-extended product was determined by comparison with sequencing ladders generated by using the same primer and the single-stranded DNA template containing the BbrPI gene ranging from nucleotides 2 (BamHI site) to 1066 (PstI site) (see Fig. 3 ).
Other analytical procedures. SDS-PAGE was performed as described by Laemmli (14) . The amino-terminal amino acid sequences of the purified PIs were determined with a gasphase protein sequencer (ABI model 477A-120A). Samples for sequence analysis were prepared by the method of Matsudaira (17) . The isoelectric point of BbrPI was determined by using Isogel plates (FMC Bioproducts, Rockland, Maine) with marker proteins (Oriental Yeast Co., Osaka, Japan). Heat treatment was done by incubating BbrPI (about 0.3 mg/ml) in 50 mM buffer of various pHs. The hydropathy of the PI was calculated by the method of Kyte and Doolittle (13) , with a span of nine amino acid residues.
Nucleotide sequence accession number. The DDBJ/EMBL accession number for the BbrPI gene sequence is D01106.
RESULTS
Multiform protease inhibitors in B. brevis. Strong inhibitor activity toward trypsin was found in the culture supernatant of B. brevis HPD31, while no activity was detected in the cell extract. After purification (see below), proteins exhibiting PI activity in the supernatant were separated into three bands corresponding to approximate molecular weights of 28,000 to 30,000 on SDS-PAGE (Fig. 1A) . Although separation of band b from band c is not clear in Fig. 1A , the two close but distinct bands could be seen when a smaller amount of protein was applied to the gel.
Purification and characterization of B. brevis PIs. A proteinaceous inhibitor was purified from the culture supernatant of B. brevis HPD31, as described in Materials and Methods. The purified inhibitor, designated PI-a, gave a single stained band on SDS-PAGE, and its molecular weight was estimated to be 28,000 (Fig. 1A) . The effects of the inhibitor on various proteases were examined and are shown in Table 1 . The enzymes were preincubated with various amounts of the inhibitor, and changes in enzyme activities were measured by using appropriate substrates. PI-a inhibited trypsin, chymotrypsin, subtilisin, and plasmin, which are all serine proteases, but did not inhibit any of the metal and thiol proteases tested. A stoichiometric titration curve for trypsin and PI-a is shown in Fig. 2 . If 22,000 (from sequence data) rather than 28,000 is taken as the molecular weight of PI-a, 1 mol of PI-a is required for complete inhibition of 1 mol of trypsin, suggesting the formation of an enzyme-inhibitor complex in a molar ratio of 1:1.
The isoelectric points of PI-a and its precursor (see below) were estimated to be pH 4.2 and 4.3, respectively. These values are similar to those of the known bacterial inhibitors. The PI activity did not change on heating at 95°C for 30 min at several pHs between 2.0 and 7.5, while the activity was completely lost with the same heat treatment at pHs higher than 9.
The purified PI-b and -c showed properties similar to those of PI-a with respect to stoichiometry in trypsin inhibition and heat stability, but their properties were not studied in detail, because they could not be purified in sufficient amounts.
Western blot analysis of inhibitors. When the culture supernatant was subjected to SDS-PAGE and examined by Western blotting (immunoblotting), using anti-PI-a serum, four bands were detected (Fig. 1B) . The protein in the fourth band, which could not be seen by staining of the gel and was obviously distinct from PI-a, -b, or -c, had a molecular weight of 35,000. The fourth-band protein was extracted from the gel after SDS-PAGE. The protein thus obtained showed much weaker inhibitory activity than the same amount of PI-a. Under the conditions used to measure the inhibitor activity (i.e., in the presence of trypsin), the fourth-band protein was found to be degraded, yielding protein bands corresponding to PI-a, -b, and -c on SDS-PAGE (data not shown). Therefore, it is inferred that the protein of the fourth band is a precursor of the multi-PIs and has no or only weak inhibitory activity toward trypsin. The time course of the formation of PI-a antiserum-cross-reacting proteins (Fig. 1B) also indicates that the fourth-band protein was produced at an early cultivation time, while the PI proteins appeared at the stationary phase of growth. Hereafter, the protein of the fourth band is referred to as the PI precursor.
Amino-terminal amino acid sequences of B. brevis PIs. The amino-terminal amino acid sequences of PI-a and -b and the PI precursor, determined chemically, were FVDEILQAE VNVXDD, TLGAEPRLL, and TSEPQXEL (X was not identified), respectively. The amino-terminal sequence of PI-c was identical to that of PI-b.
Nucleotide sequence of the BbrPI gene. Analysis of the DNA sequence, consisting of 1,517 bp, revealed that there is one open reading frame in the fragment (Fig. 3) , oriented from the KpnT site to the second Pstl site (Fig. 4) Fig. 3]) . The amino acid sequence from 1 to 24 showed characteristics typical of signal peptides of secretory precursors, i.e., two positively charged residues near the amino terminus followed by a hydrophobic stretch (33) . The amino-terminal amino acid sequences of PI-a and PI-b (PI-c) were found at amino acids 122 through 136 and 104 through 112, respectively (Fig. 3) , suggesting that PI-a,
.,E- -b, and -c are products resulting from processing of the PI precursor. Since the amino-terminal amino acid sequences of PI-b and -c are the same and yet PI-c is a little larger than PI-b (Fig. 1A) , PI-b is likely produced through the deletion of part of the carboxyl-terminal region of PI-c. These results clearly demonstrate that the cloned DNA is the gene coding for the PI of B. brevis. The sequence from nucleotides 454 to 458 shows some homology to the 3'-terminal sequence of B. brevis 16S rRNA (12) , suggesting that the sequence acts as a ribosomal binding sequence.
The transcription initiation site determined by the primer extension method was at nucleotide 427 (Fig. 5) . A sequence homologous to the consensus sequences recognized by the o# RNA polymerase of B. subtilis (34) was found upstream from the transcription initiation site at position -35 (TTGAAA), but not at position -10. In the 3'-flanking region of the gene, a palindromic sequence that could form a stable stem-and-loop structure (AG = -31 kcal [-130 kJ]/mol; nucleotides 1456 through 1487) followed by an A+T-rich sequence was found, which is characteristic of rho-independent transcriptional terminators of E. coli.
Characteristics of the amino acid sequence of the B. brevis PI. An homology search for the amino acid sequence deduced from the nucleotide sequence of the PI gene was performed in the National Biomedical Research Foundation protein sequence data bank, using the SEQHP Program. No sequence homology higher than 20% was observed. Figure 6 shows the hydropathy profile of PI. As this profile suggests, a PI-a molecule may have two domains which are similar to each other. Two identical residues, suggesting that the gene evolved through duplication.
Overproduction of the B. brevis PI. B. brevis HPD31 was transformed with the composite plasmid pYAS03, which is described in Materials and Methods. The time course of PI production by the transformant is shown in Fig. 7 Rather unexpectedly, BbrPI was found to show no significant homology with any of the known PIs. This is probably a reflection of the highly varied structures of the reactive sites of bacterial proteases. Since tight binding to the reactive-site regions of proteases is the only function of PIs, PIs might have evolved from various protein molecules or through accelerated alteration in the reactive-center region of a prototype molecule (10) . Hypervariability of the PTenzyme contact region has been found in eucaryotic PIs (16) .
The topological relationship between the disulfide linkages and the location of the reactive site are important criteria for the classification of PIs from eucaryotic cells and Streptomyces PI (15) . In contrast to these PIs, BbrPI has no cysteine residue, suggesting that a disulfide linkage is not necessary for binding activity. Regardless of the presence or absence of a disulfide bond, all PIs are known to be very thermostable. This is probably due to the simple structural requirement for PIs; i.e., only the binding site to the reactive-site region of the protease is essential.
B. brevis HPD31 secretes vast amounts of proteins, but shows little protease activity in the medium. A host-vector system for the production of heterologous proteins has been developed involving this bacterium as a host (31) . Many bacterial and mammalian proteins have been produced efficiently with this system (31, 35) . Use of the BbrPI-hyperproducing B. brevis strain constructed here may further improve the efficiency of very unstable heterologous protein production.
Arima et al. detected PI activity in the culture supernatants of several Bacillus species (2) , and the PIs ofB. subtilis and Streptomyces species have been well characterized, as mentioned already. Since many other bacterial PIs are expected to be found, we propose that they be named as follows: an abbreviation of each organism's name (the first letter of the genus name and the first two letters of the species name) followed by PI. For example, the PIs of B.
brevis and E. coli will be designated BbrPI and EcoPI, respectively.
